Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative?

1999 ◽  
Vol 116 (5) ◽  
pp. 1246-1249 ◽  
Author(s):  
Massimo Campieri ◽  
Paolo Gionchetti
2019 ◽  
Vol 26 (2) ◽  
pp. 216-228 ◽  
Author(s):  
Thangaraj Karuppuchamy ◽  
Christopher J Tyler ◽  
Luke R Lundborg ◽  
Tamara Pérez-Jeldres ◽  
Abigail K Kimball ◽  
...  

Sphingosine-1-phosphate (S1P) receptor agonists are a promising therapeutic alternative to anti-integrin antibodies in inflammatory bowel disease. Here, we report that modulation of tissue S1P levels via inhibition of the S1P lyase might be an effective alternative, acting by interference with thymocyte maturation.


2001 ◽  
Vol 120 (5) ◽  
pp. A455-A455
Author(s):  
E MANNICK ◽  
M SERRANO ◽  
J BONOMOLO ◽  
M LAU ◽  
J UDALLJR ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document